An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia

Local Institution, New Taipei City

Local Institution, Kaohsiung City

NYU Langone Medical Center, New York

Local Institution, Milan

Local Institution, New Taipei City

Duke University Adult Bone Marrow Transplant Clinic, Durham

UF Health Cancer Center at Orlando Health, Orlando

Local Institution, Taoyuan

Norton Cancer Institute, Louisville

Cleveland Clinic Taussig Cancer Center, Cleveland

University Of Cincinnati, Cincinnati

Froedtert Hospital & Medical College of Wisconsin, Milwaukee

The University Of Texas MD Anderson Cancer Center, Houston

Azienda Ospedaliera Di Rilievo Nazionale A. Cardarelli, Napoli

Local Institution, Jerusalem

Local Institution, Tel Aviv

Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele, Catania

Local Institution, Bunkyo-ku

Local Institution, Shinagawa-ku

Local Institution, Shinjuku-Ku

Local Institution, Tachikawa

Local Institution, Isehara

Local Institution, Nagoya

Local Institution, Hirakata-shi

Local Institution, Fukuyama-shi

Ucla Center Health Sci, Los Angeles

Liga Paranaense De Combate Ao Cancer Erasto Gaertner, Curitiba

Instituto Do Cancer Mae De Deus / Cor Hospital Mae De Deus, Porto Alegre

Fundacao Pio Xii Hosp Cancer De Barretos, Barretos

IEP Sao Lucas, São Paulo

Local Institution, São Paulo

Local Institution, São Paulo

Local Institution, Halifax

Local Institution, Hong Kong

Local Institution, Roma

Local Institution, Bucharest

Local Institution, Seoul

Local Institution, Seoul